1. Home
  2. KVYO vs BIO Comparison

KVYO vs BIO Comparison

Compare KVYO & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVYO
  • BIO
  • Stock Information
  • Founded
  • KVYO 2012
  • BIO 1952
  • Country
  • KVYO United States
  • BIO United States
  • Employees
  • KVYO N/A
  • BIO N/A
  • Industry
  • KVYO
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • KVYO
  • BIO Industrials
  • Exchange
  • KVYO Nasdaq
  • BIO Nasdaq
  • Market Cap
  • KVYO 8.8B
  • BIO 9.2B
  • IPO Year
  • KVYO 2023
  • BIO N/A
  • Fundamental
  • Price
  • KVYO $30.97
  • BIO $243.64
  • Analyst Decision
  • KVYO Buy
  • BIO Strong Buy
  • Analyst Count
  • KVYO 19
  • BIO 4
  • Target Price
  • KVYO $49.16
  • BIO $415.25
  • AVG Volume (30 Days)
  • KVYO 1.5M
  • BIO 396.8K
  • Earning Date
  • KVYO 05-07-2025
  • BIO 05-06-2025
  • Dividend Yield
  • KVYO N/A
  • BIO N/A
  • EPS Growth
  • KVYO N/A
  • BIO N/A
  • EPS
  • KVYO N/A
  • BIO N/A
  • Revenue
  • KVYO $937,464,000.00
  • BIO $2,566,500,000.00
  • Revenue This Year
  • KVYO $26.40
  • BIO $1.11
  • Revenue Next Year
  • KVYO $21.77
  • BIO $4.55
  • P/E Ratio
  • KVYO N/A
  • BIO N/A
  • Revenue Growth
  • KVYO 34.29
  • BIO N/A
  • 52 Week Low
  • KVYO $21.26
  • BIO $241.87
  • 52 Week High
  • KVYO $49.55
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • KVYO 33.11
  • BIO 32.66
  • Support Level
  • KVYO $32.06
  • BIO $243.76
  • Resistance Level
  • KVYO $34.54
  • BIO $249.37
  • Average True Range (ATR)
  • KVYO 1.49
  • BIO 7.41
  • MACD
  • KVYO 0.17
  • BIO 1.77
  • Stochastic Oscillator
  • KVYO 4.52
  • BIO 5.34

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: